-
-
-
-
Manufacturing
-
Qilu’s Ifosfamide for Injection Joins U.S. Shortage Drug Supply, Marking the 44th FDF Export to America
ABOUT US
Qilu’s Ifosfamide for Injection Joins U.S. Shortage Drug Supply, Marking the 44th FDF Export to America
Release time：
2026-08-28
After Cisplatin injection, another Qilu product has been listed on the U.S. drug shortage drug list. On August 28, Ifosfamide for injection with China-market packaging was exported to the U.S., becoming Qilu Pharmaceutical’s 44th finished dosage form product shipped to the US.
Previous page
Related News
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail：export@qilu-pharma.com, FDF@qilu-pharma.com